| 10009898 |
(−)-11-nor-9-carboxy-Δ9-THC-d3 (solution)
|
|
130381-15-6 |
≥99% deuterated forms (d1-d3)
|
|
|
2010-11-12
|
8.249654696132
|
-11-nor-9-carboxy-9-thc-d3-solution
|
|
THC metabolites Delta9-THC Δ9 THC tetrahydrocannabinols marijuana deuterateds deuterium internal standards mass spectrometry GC/MS LC/MS GC-MS LC-MS MS cannabinoids cbs synthetic 10916 |
8.249654696132
|
| 10009897 |
(−)-11-nor-9-carboxy-Δ9-THC (solution)
|
|
56354-06-4 |
≥98%
|
|
|
2010-11-11
|
11.018646408839
|
-11-nor-9-carboxy-9-thc-solution
|
|
THC metabolites Delta9-THC Δ9-THC tetrahydrocannabinols marijuana cannabinoids cbs synthetic 10915 |
11.018646408839
|
| 10010132 |
15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester
|
|
- |
≥98% (isomer mixture)
|
|
|
2008-06-09
|
19.581055862492
|
15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester
|
15-deoxy-Δ12,14-PGJ2-2-glycerol ester
|
PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic |
19.581055862492
|
| 14810 |
17-phenyl trinor Prostaglandin E2
|
|
38315-43-4 |
>98%
|
|
|
|
59.319171270718
|
17-phenyl-trinor-prostaglandin-e2
|
17-phenyl trinor PGE2
|
agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 |
59.319171270718
|
| 10004238 |
17-phenyl trinor Prostaglandin E2 serinol amide
|
|
- |
≥95%
|
|
|
2004-05-13
|
25.834298342541
|
17-phenyl-trinor-prostaglandin-e2-serinol-amide
|
17-phenyl trinor PGE2-SA
|
agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 analogs 17-phenyl-PGE2SA 17-phenyl-PGE2-SA amides cannabinoids Cbs sythetic |
25.834298342541
|
| 10004237 |
17-phenyl trinor Prostaglandin F2α serinol amide
|
|
- |
≥98%
|
|
|
2004-03-15
|
6.814792817679
|
17-phenyl-trinor-prostaglandin-f2-serinol-amide
|
17-phenyl trinor PGF2α-SA; Bimatoprost serinol amide
|
analogs agonists receptors 17-phenyl-PGF2.alpha.SA 17-phenyl-PGF2alphaSA 17-phenyl-PGF2a-SA prostaglandins cannabinoids CBs synthetic |
6.814792817679
|
| 362152 |
1-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
|
36.490704419889
|
1-arachidonoyl-glycerol-d5
|
1-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic |
36.490704419889
|
| 11687 |
1'-Naphthoyl Indole
New
|
|
109555-87-5 |
≥98%
|
|
|
2012-05-01
|
100.035968650112
|
1-naphthoyl-indole
|
|
indol-3-yl 1-naphthyl ketones synthetic cannabinoids CBs receptors CB1 central CB2 peripheral napthoylindole indoles herbals blends recreational cannabimimetics N-alkyl chains forensics designer drugs incense |
100.035968650112
|
| 10008602 |
20-HETE Ethanolamide
|
|
- |
≥98%
|
|
|
2006-09-26
|
42.358876611418
|
20-hete-ethanolamide
|
20-hydroxy AEA; 20-hydroxy Arachidonoyl Ethanolamide
|
hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction ethanolamides cannabinoids cbs synthetic |
42.358876611418
|
| 10009962 |
2-(14,15-Epoxyeicosatrienoyl) Glycerol
|
|
848667-56-1 |
≥95%
|
|
|
2008-04-03
|
39.494825046040
|
2-14-15-epoxyeicosatrienoyl-glycerol
|
2-14,15-EG
|
2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic |
39.494825046040
|
| 362162 |
2-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
|
47.930980662983
|
2-arachidonoyl-glycerol-d5
|
2-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
47.930980662983
|
| 362160 |
2-Arachidonoyl Glycerol-d8
|
|
- |
≥99% deuterated forms (d1-d8)
|
|
|
|
84.020801104972
|
2-arachidonoyl-glycerol-d8
|
2-AG-d8
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
84.020801104972
|
| 10918 |
(±)3-epi CP 47,497-C8-homolog
|
|
- |
≥98%
|
|
|
2011-05-06
|
9.598423751790
|
-3-epi-cp-47-497-c8-homolog
|
|
(±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 |
9.598423751790
|
| 13802 |
(±)3-epi CP 47,497-C8-homolog (solution)
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-08-04
|
9.270452402875
|
-3-epi-cp-47-497-c8-homolog-solution
|
|
(±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 |
9.270452402875
|
| 13140 |
4-(n-nonyl) Benzeneboronic Acid
|
|
256383-45-6 |
≥98%
|
|
|
2009-11-04
|
6.628153775322
|
4-n-nonyl-benzeneboronic-acid
|
|
fatty acids amide hydrolase FAAH endocannabinoids arachidonoyl ethanolamides AEA inhibitors inhibit monoacylglycerol lipase MAGL 2-arachidonoyl glycerol 2-AG 2AG 2 AG inhibition cannabinoids cbs synthetic |
6.628153775322
|
| 11093 |
4-Quinolone-3-Carboxamide CB2 Ligand
New
|
|
1314230-69-7 |
≥98%
|
|
|
2012-01-30
|
29.832711699173
|
4-quinolone-3-carboxamide-cb2-ligand
|
4Q3C CB2 Ligand
|
CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 |
29.832711699173
|
| 11094 |
4-Quinolone-3-Carboxamide Furan CB2 Agonist
New
|
|
1314230-75-5 |
≥98%
|
|
|
2012-02-28
|
32.235202229476
|
4-quinolone-3-carboxamide-furan-cb2-agonist
|
4Q3C CB2 Agonist
|
cannabinoids CBs agonists receptors CB1 CB2 AM630 pain neuroscience osteoporosis inflammation anti-inflammatory bones research peripheral AM630 AM 630 AM-630 |
32.235202229476
|
| 13803 |
(±)5-epi CP 55,940
|
|
- |
≥98%
|
|
|
2010-08-04
|
8.949804118533
|
-5-epi-cp-55-940
|
|
(±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 |
8.949804118533
|
| 10005764 |
8-iso Prostaglandin F2α Ethanolamide
|
|
- |
>98%
|
|
|
2004-09-24
|
34.617771639042
|
8-iso-prostaglandin-f2-ethanolamide
|
8-Isoprostane Ethanolamide; 8-epi PGF2α Ethanolamide; 8-iso PGF2α Ethanolamide; iPF2α-III Ethanolamide
|
ethanolamides prostaglandins anandamides AEA COX-2 cox2 cyclooxygenases synthases isoprostanes 8-epi-PGF2alpha 8-iso-PGF2alpha arachidonoyl prostamides congeners decomposition standards non-enzymatic iPF2a-III PGHS2 PGHS-2 ethanolamines 714966-38-8 cannabinoids cbs sythetic |
34.617771639042
|
| 11566 |
AKB48
Exclusive New
|
|
1345973-53-6 |
≥98%
|
|
✓ |
2012-04-30
|
346.902866392707
|
akb48
|
APINACA
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetics AKB 48 AKB-48 JWH018 JWH18 JWH 018 adamantyl carboxamide JWH-018 JWH 18 JWH-18 peripheral central 9001193 11564 STS-135 STS 135 STS135 |
346.902866392707
|
| 10005223 |
AM1172
|
|
251908-92-6 |
>98%
|
|
|
2004-09-01
|
24.112353433011
|
am1172
|
|
cannabinoids neurotransmitters inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids inhibits arachidonoyl ethanolamides reuptake FAAH-resistant amide hydrolases neuroscience neurochemistry cannabinoids cbs synthetic |
24.112353433011
|
| 9001055 |
AM1220
|
|
137642-54-7 |
≥98%
|
|
|
2011-10-11
|
95.776710483354
|
am1220
|
[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthalenyl-methanone
|
AM-2201 AM 2201 AM-1220 AM 1220 cannabinoids CB1 CB2 CBs receptors pains forensic science forensics |
95.776710483354
|
| 11583 |
AM1220 azepane isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-05-15
|
154.933505217925
|
am1220-azepane-isomer
|
|
cannabinoids CB1 herbals spices forensics cannabimimetics receptors agonists neurosciences CBs CB2 central peripheral AM-1220 AM 1220 isomers |
154.933505217925
|
| 9001094 |
AM1235
Exclusive New
|
|
335161-27-8 |
≥98%
|
|
✓ |
2012-04-20
|
126.136499386126
|
am1235
|
|
cannabinoids CBs herbals incense receptors agonists CB1 CB2 forensics AM-1235 AM 1235 synthetic |
126.136499386126
|
| 10010118 |
AM1241
|
|
444912-48-5 |
≥97%
|
|
|
2007-08-29
|
98.893354337934
|
am1241
|
|
CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic AM1243 AM-1243 1243 |
98.893354337934
|
| 11282 |
AM1248
Exclusive New
|
|
335160-66-2 |
≥98%
|
|
✓ |
2012-02-06
|
65.101985322061
|
am1248
|
|
CBs cannabinoids synthetic agonist AM-1248 AMs 1248 forensic sciences receptors CB1 CB2 1-pentyl-3-(1-adamantoyl)indole AM679 AM-679 679 herbal blends smart products |
65.101985322061
|
| 10707 |
AM2201
|
|
335161-24-5 |
≥98%
|
|
|
2011-03-07
|
130.054011314727
|
am2201
|
|
cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM-2201 AM 2201 |
130.054011314727
|
| 11194 |
AM2201 2-hydroxyindole metabolite
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-05-15
|
102.711743400859
|
am2201-2-hydroxyindole-metabolite
|
|
forensic sciences isomers cannabinoids CB1 CB2 urinary metabolites CBs central peripheral receptors AM-2201 AM 2201 |
102.711743400859
|
| 10862 |
AM2201 2'-naphthyl isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-06
|
81.366833621524
|
am2201-2-naphthyl-isomer
|
|
AM-2201 AM 2201 cannabinoids CBs isomers AMs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices synthetics |
81.366833621524
|
| 11192 |
AM2201 6-hydroxyindole metabolite
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-02-28
|
64.736433003919
|
am2201-6-hydroxyindole-metabolite
|
|
cannabinoids CBs CB1 CB2 receptors pain forensic science neuroscience metabolites AM-2201 AM 2201 synthetic central peripheral P450 P-450 cytochromes blood urine |
64.736433003919
|
| 11193 |
AM2201 7-hydroxyindole metabolite
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-01-16
|
66.198490982941
|
am2201-7-hydroxyindole-metabolite
|
|
forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 metabolites urinary urine metabolism synthetic central peripheral |
66.198490982941
|
| 10706 |
AM2201-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1- d5)
|
|
✓ |
2011-05-16
|
53.678816923285
|
am2201-d5
|
|
cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards |
53.678816923285
|
| 9001031 |
AM2201 N-(2-fluoropentyl) isomer
Exclusive New
|
|
- |
≥95%
|
|
✓ |
2011-12-15
|
85.204461174323
|
am2201-n-2-fluoropentyl-isomer
|
|
forensics AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 synthetic isomers fluorine pentyl chains synthetic central peripheral |
85.204461174323
|
| 9001030 |
AM2201 N-(3-fluoropentyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-11-22
|
77.589468235752
|
am2201-n-3-fluoropentyl-isomer
|
|
forensics AM-2201 AM 2201 isomers cannabinoids CBs receptors pain CBs CB1 CB2 |
77.589468235752
|
| 9001029 |
AM2201 N-(4-fluoropentyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-08-11
|
89.033418511995
|
am2201-n-4-fluoropentyl-isomer
|
|
forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 central peripheral |
89.033418511995
|
| 10203 |
AM2201 N-(4-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
122.314144531919
|
am2201-n-4-hydroxypentyl-metabolite
|
|
AM-2201 AM 2201 cannabinoids cannabimimetic metabolites CB1 CB2 CBS receptors forensics synthetics smoking urinary urine potent synthetic |
122.314144531919
|
| 11457 |
AM2201 N-(4-hydroxypentyl) metabolite-d5
Exclusive New
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2012-03-13
|
109.116260245029
|
am2201-n-4-hydroxypentyl-metabolite-d5
|
|
cannabinoids central peripheral metabolites CB1 CB2 receptors pain forensic sciences synthetics smoking urinary urine potent CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards |
109.116260245029
|
| 11503 |
AM2232
New
|
|
335161-19-8 |
≥95%
|
|
|
2012-03-29
|
93.166883692332
|
am2232
|
|
cannabinoids CBs CB1 CB2 central peripheral receptors forensics herbals incense agonists AM-2232 AM 2232 AMS |
93.166883692332
|
| 11008 |
AM2233
|
|
444912-75-8 |
≥98%
|
|
|
2011-10-24
|
109.136584896401
|
am2233
|
|
769958-75-0 forensic science cannabinoid receptors CB1 agonists WIN 55,212-2 WIN 55212-2 radioligands neuroscience |
109.136584896401
|
| 11584 |
AM2233 azepane isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-05-08
|
163.905113566605
|
am2233-azepane-isomer
|
|
cannabinoids CBs CB1 herbals spices forensics cannabimimetics agonists receptors neuroscience AM 2233 AM-2233 isomer 11008 |
163.905113566605
|
| 71670 |
AM251
|
|
183232-66-8 |
>98%
|
|
|
|
97.388179650992
|
am251
|
|
cannabinoids receptors antagonists CB1 analogs selective SR-141716-A AM-251 SR141716A neuroscience neurochemistry endocrinology |
97.388179650992
|
| 13452 |
AM3102
Exclusive
|
|
213182-22-0 |
≥98%
|
|
✓ |
2009-08-11
|
40.003752932898
|
am3102
|
KDS-5104
|
OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic |
40.003752932898
|
| 90060 |
AM404
|
|
183718-77-6 |
>98%
|
|
|
|
33.186357081109
|
am404
|
N-(4-hydroxyphenyl)-Arachidonoyl Amide; 4-HPA
|
cannabinoids neurotransmitter inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids neuroscience neurochemistry |
33.186357081109
|
| 10006974 |
AM630
|
|
164178-33-0 |
≥98%
|
|
|
2009-02-09
|
47.443079312365
|
am630
|
Iodopravadoline
|
neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors |
47.443079312365
|
| 11504 |
AM679
Exclusive New
|
|
335160-91-3 |
≥98%
|
|
✓ |
2012-04-27
|
108.225876043367
|
am679
|
|
ams AM-679 AM 679 central peripheral receptors cannabinoids CBs CB1 CB2 incense agonists forensics spices designer drugs synthetic |
108.225876043367
|
| 10567 |
AM694
Exclusive
|
|
335161-03-0 |
≥95%
|
|
✓ |
2011-01-31
|
60.006351580004
|
am694
|
|
cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 |
60.006351580004
|
| 10870 |
AM694 3-iodo isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-08-31
|
54.127277000140
|
am694-3-iodo-isomer
|
|
cannabinoids CBs cannabimimetic CB1 receptors agonists CB2 forensics sciences isomers AM 694 AM-694 synthetic analogs methanone indoles potent 3 iodo |
54.127277000140
|
| 10869 |
AM694 4-iodo isomer
Exclusive
|
|
- |
≥97%
|
|
✓ |
2011-06-21
|
41.204834254143
|
am694-4-iodo-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 pain spices forensics synthetic receptors agonists AM-694 AM 694 analogs neuroscience |
41.204834254143
|
| 10008617 |
Arachidonic Acid Leelamide
|
|
- |
≥95%
|
|
|
2006-09-27
|
14.271160220994
|
arachidonic-acid-leelamide
|
|
AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic |
14.271160220994
|
| 10007904 |
Arachidonoyl-1-thio-Glycerol
Exclusive
|
|
- |
≥98%
|
|
✓ |
2006-01-24
|
17.398674033149
|
arachidonoyl-1-thio-glycerol
|
1-S-Arachidonoyl-1-mercapto-2,3-propanediol
|
cannabinoids monoacylglycerols monoglycerol monoglyceride anandamides fatty acids neurochemistry neuroscience chromogenic substrates lipases 2-arachidonoyls 2-AG agonists central CB1 nervous system CNS rat brains MGL hydrolyzes arachidonic acids thioesters analogs thiols DTNB Ellman's reagents yellow cannabinoids cbs synthetic |
17.398674033149
|
| 10011178 |
Arachidonoyl Ethanolamide-d4
|
|
946524-40-9 |
≥99% deuterated forms (d1-d4)
|
|
|
2008-03-04
|
40.586823204420
|
arachidonoyl-ethanolamide-d4
|
AEA-d4; Anandamide-d4
|
deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
40.586823204420
|
| 10180 |
Arachidonoyl Ethanolamide Phosphate
|
|
183323-26-4 |
>98%
|
|
|
2004-08-19
|
21.402127071823
|
arachidonoyl-ethanolamide-phosphate
|
AEA-P; Anandamide Phosphate
|
endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors fatty acids phosphates anandamides LPA lysophosphatidic ethanolamines ethanolamides cannabinoids cbs synthetic |
21.402127071823
|
| 62170 |
Arachidonoyl Serinol
|
|
183718-70-9 |
>98%
|
|
|
|
37.453093922652
|
arachidonoyl-serinol
|
|
endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic |
37.453093922652
|
| 13823 |
AX 048
Exclusive
|
|
873079-69-7 |
≥98%
|
|
✓ |
2010-09-15
|
7.192651933702
|
ax-048
|
|
Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids |
7.192651933702
|
| 10506 |
Bio-active Lipid I Screening Library (96-Well)
|
|
- |
|
|
|
2010-06-15
|
39.676215469613
|
bio-active-lipid-i-screening-library-96-well
|
|
vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandins HTS high thoroughput screening cannabinoids cbs synthetic |
39.676215469613
|
| 90080 |
Cannabidiol
|
|
13956-29-1 |
>99%
|
|
|
|
31.817340173638
|
cannabidiol
|
CBD
|
delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids |
31.817340173638
|
| 13285 |
Cannabidiol dimethyl ether
|
|
1242-67-7 |
≥98%
|
|
|
2009-05-19
|
8.183425414364
|
cannabidiol-dimethyl-ether
|
Cannabidiol-2',6'-dimethyl ether; CBDD
|
15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic |
8.183425414364
|
| 90081 |
Cannabidiol (solution)
|
|
13956-29-1 |
≥99%
|
|
|
2011-03-03
|
45.111998995479
|
cannabidiol-solution
|
CBD
|
delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids |
45.111998995479
|
| 10508 |
Cannabinoid Agonist Screening Library (96-Well)
|
|
- |
|
|
|
2011-05-05
|
16.574585635359
|
cannabinoid-agonist-screening-library-96-well
|
|
plates screening cannabinoids CBs libraries
foresnics JWHs JWH-108 JWH-200 HU 210 CPs |
16.574585635359
|
| 71652 |
CAY10401
|
|
288862-89-5 |
>98%
|
|
|
2005-02-02
|
7.964372007366
|
cay10401
|
|
FAAH inhibitors analgesics fatty acids amides hydrolases inhibits inhibition hydrolysis hydrolyze CAY-10401 inactivation anandamides AEA arachidonoyl ethanolamides neuroscience neurochemistry cannabinoids cbs synthetic |
7.964372007366
|
| 10009523 |
CAY10429-d3
|
|
- |
≥99% deuterated forms (d1-d3)
|
|
|
2007-10-02
|
4.785082872929
|
cay10429-d3
|
Abnormal Cannabidiol-d3; Abn-CBD-d3
|
endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic |
4.785082872929
|
| 10008669 |
CAY10508
|
|
878533-35-8 |
≥98%
|
|
|
2006-08-04
|
35.284060773480
|
cay10508
|
|
1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic |
35.284060773480
|
| 10010398 |
CB-13
|
|
432047-72-8 |
≥98%
|
|
|
2009-06-30
|
38.500490737732
|
cb-13
|
CRA-13
|
cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 |
38.500490737732
|
| 10006590 |
CB1 Receptor (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2005-05-10
|
74.772228360957
|
cb1-receptor-c-term-polyclonal-antibody
|
Cannabinoid Receptor 1
|
cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB IHC immunohistochemistry neuroscience neurochemistry endocrinology immunoblotting cannabinoids cbs synthetic |
74.772228360957
|
| 10010116 |
CB-25
Exclusive
|
|
869376-63-6 |
>98%
|
|
✓ |
2007-10-25
|
20.448853591160
|
cb-25
|
|
cannabinoids ligands receptors CB1 CB2 THC anandamides AEA inverse agonists cannabinoids cbs synthetic |
20.448853591160
|
| 10010117 |
CB-52
Exclusive
|
|
869376-90-9 |
≥98%
|
|
✓ |
2007-10-25
|
20.362948895028
|
cb-52
|
|
cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic |
20.362948895028
|
| 13289 |
CB-86
Exclusive
|
|
1150586-64-3 |
≥98%
|
|
✓ |
2010-05-03
|
23.170741910023
|
cb-86
|
|
cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione
6-Azauridine 6 Azauridine
Azauridine cannabinoids cbs synthetic |
23.170741910023
|
| 10917 |
(−)-CP 47, 497
|
|
114753-51-4 |
≥98%
|
|
|
2011-05-05
|
12.763946616612
|
-cp-47-497
|
|
cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 13218 |
12.763946616612
|
| 10910 |
(+)-CP 47,497
|
|
134308-14-8 |
≥98%
|
|
|
2011-05-05
|
13.281073688435
|
-cp-47-497
|
|
cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids |
13.281073688435
|
| 10913 |
(±)-CP 47,497
|
|
70434-82-1 |
≥98%
|
|
|
2011-05-05
|
34.382032339974
|
-cp-47-497
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 |
34.382032339974
|
| 9000774 |
(±)-CP 47,497-C7-hydroxy metabolite
|
|
- |
≥95%
|
|
|
2011-11-04
|
66.972189993861
|
-cp-47-497-c7-hydroxy-metabolite
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic metabolites herbal adulterant CP47,497 CP-47,497 |
66.972189993861
|
| 10908 |
(±)-CP 47,497-C8-homolog
Exclusive
|
|
70434-92-3 |
≥98%
|
|
✓ |
2011-05-06
|
33.614779595787
|
-cp-47-497-c8-homolog
|
CAY10596; Cannabicyclohexanol
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic |
33.614779595787
|
| 9000773 |
CP 47,497-C8-homolog C-8-hydroxy metabolite
New
|
|
- |
≥98%
|
|
|
2012-01-03
|
24.703571209330
|
cp-47-497-c8-homolog-c-8-hydroxy-metabolite
|
|
cannabinoids cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic CP-47497 CP 47,497 47,497 CPs CP47497 CP47,497 herbal blends CBs monophenols adulterant metabolites |
24.703571209330
|
| 10686 |
(±)-CP 47,497-C8-homolog-d7 (solution)
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-03-14
|
25.726973152059
|
-cp-47-497-c8-homolog-d7-solution
|
Cannabicyclohexanol-d7
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 |
25.726973152059
|
| 13216 |
(±)-CP 47,497-C8-homolog (solution)
Exclusive
|
|
70434-92-3 |
≥98%
|
|
✓ |
2009-04-23
|
43.928671821398
|
-cp-47-497-c8-homolog-solution
|
CAY10596; Cannabicyclohexanol
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 |
43.928671821398
|
| 10687 |
(±)-CP 47,497-d11 (solution)
Exclusive
|
|
- |
≥99% deuterated forms (d1-d11)
|
|
✓ |
2011-02-16
|
34.319074410242
|
-cp-47-497-d11-solution
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 |
34.319074410242
|
| 10889 |
CP 47,497-para-quinone analog
Exclusive
|
|
- |
≥90%
|
|
✓ |
2011-07-13
|
12.459427767546
|
cp-47-497-para-quinone-analog
|
|
CP47,497 CP-47,497 analogs cannabinoids CBs forensics sciences quinones paraquinone CP47497 CP-47497 47497 47,497 cannabimimetics CB1 CB2 receptors agonists spices synthetics |
12.459427767546
|
| 13218 |
(−)-CP 47,497 (solution)
|
|
114753-51-4 |
≥98%
|
|
|
2009-04-13
|
17.412952685231
|
-cp-47-497-solution
|
|
cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 10917 |
17.412952685231
|
| 13219 |
(+)-CP 47,497 (solution)
|
|
134308-14-8 |
≥98%
|
|
|
2009-04-13
|
18.224339434425
|
-cp-47-497-solution
|
|
cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 |
18.224339434425
|
| 16851 |
(±)-CP 47,497 (solution)
|
|
70434-82-1 |
≥98%
|
|
|
2008-12-10
|
49.485946899938
|
-cp-47-497-solution
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 |
49.485946899938
|
| 90084 |
(−)-CP 55,940
|
|
83002-04-4 |
≥98%
|
|
|
2007-01-15
|
42.173747156320
|
-cp-55-940
|
|
CP 55940 CP-55940 CP-55,940 agonists cannabinoids CB1 CB2 THC receptors endocrinology cp55940 cp55,940 neurochemistry cbs synthetic |
42.173747156320
|
| 13608 |
(+)-CP 55,940
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-05-20
|
22.036376965575
|
-cp-55-940
|
|
Δ9-THC cannabinoids CB1 CB2 pain analgesic cannabinoids cbs synthetic |
22.036376965575
|
| 13241 |
(±)-CP 55,940
Exclusive
|
|
83003-12-7 |
≥98%
|
|
✓ |
2009-05-20
|
21.967687152834
|
-cp-55-940
|
|
cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic |
21.967687152834
|
| 10007534 |
Docosahexaenoyl Ethanolamide
Exclusive
|
|
162758-94-3 |
≥98%
|
|
✓ |
2006-02-17
|
20.422555781719
|
docosahexaenoyl-ethanolamide
|
DHEA; DEA
|
neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA |
20.422555781719
|
| 9001108 |
Docosahexaenoyl Ethanolamide-d4
Exclusive New
|
|
946524-43-2 |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2012-02-21
|
19.810945429872
|
docosahexaenoyl-ethanolamide-d4
|
DHEA-d4; DEA-d4
|
neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry LC/MS MS |
19.810945429872
|
| 10964 |
Eicosapentaenoyl Ethanolamide
|
|
109001-03-8 |
≥98%
|
|
|
2011-06-22
|
57.375516969219
|
eicosapentaenoyl-ethanolamide
|
EPEA
|
cannabinoids CBSs endocannabinoids forensic sciences signals signaling N-acylethanolamide N-acylethanolamine NAE dietary restrictions lifespans TOR nematodes eicosapentaenoic acids inflammation anti-inflammatory |
57.375516969219
|
| 10919 |
(±)-epi CP 47, 497
|
|
- |
≥98%
|
|
|
2011-05-05
|
9.598423751790
|
-epi-cp-47-497
|
3-trans CP 47,497
|
(±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 |
9.598423751790
|
| 13801 |
(±)-epi CP 47,497 (solution)
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-08-04
|
9.334116612362
|
-epi-cp-47-497-solution
|
3-trans CP 47,497
|
(±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 |
9.334116612362
|
| 10004236 |
Fluprostenol serinol amide
|
|
- |
≥98%
|
|
|
2004-09-23
|
7.056596685083
|
fluprostenol-serinol-amide
|
Flu-SA
|
PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic |
7.056596685083
|
| 10011357 |
Glycerophospho-N-Oleoyl Ethanolamine
Exclusive
|
|
201738-24-1 |
≥98%
|
|
✓ |
2009-02-20
|
24.612817679558
|
glycerophospho-n-oleoyl-ethanolamine
|
|
cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic |
24.612817679558
|
| 10011356 |
Glycerophospho-N-Palmitoyl Ethanolamine
Exclusive
|
|
100575-09-5 |
≥98%
|
|
✓ |
2009-03-12
|
7.585174953959
|
glycerophospho-n-palmitoyl-ethanolamine
|
GP-NPEA; GP-NAE
|
cannabinoids neurotransmitter neurochemistry neuroscience fatty acids amides hydrolase FAAHs palmitoyl ethanolamides inflammation anti-inflammatory C16:0 CBS NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic |
7.585174953959
|
| 10224 |
GPR55 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-19
|
42.302316495658
|
gpr55-polyclonal-antibody
|
G Protein-Coupled Receptor 55
|
proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic |
42.302316495658
|
| 10010372 |
GW 842166X
|
|
666260-75-9 |
≥98%
|
|
|
2008-05-23
|
34.145428176795
|
gw-842166x
|
|
inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic |
34.145428176795
|
| 10011038 |
Hemopressin
|
|
- |
|
|
|
2009-08-13
|
29.761006314127
|
hemopressin
|
|
peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic |
29.761006314127
|
| 10006371 |
Hormone Sensitive Lipase Polyclonal Antibody
|
|
- |
|
|
|
2005-06-22
|
9.506293738489
|
hormone-sensitive-lipase-polyclonal-antibody
|
HSL; LIPE
|
proteins antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry catalyses hydrolysis of tri- di- monoacylglycerols cholesterol esters mobilizes fatty acids primary source energy mammals enzyme expressed adipose tissues stearidonic steroidgenesis spermatogenesis foam cell formation atherosclerosis diabetic pathology human cDNA isoforms testis mRNA mouse murine macrophages testicular ram seminal vesicles triacylglycerols diacylglycerols atherosclerosis |
9.506293738489
|
| 90082 |
HU-210
|
|
112830-95-2 |
>98%
|
|
|
|
45.112620856353
|
hu-210
|
|
agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic |
45.112620856353
|
| 90083 |
HU-210 (solution)
|
|
112830-95-2 |
≥98%
|
|
|
2011-03-03
|
30.987411207576
|
hu-210-solution
|
|
agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic Tetrahydrocannabinol, Trans-(+-)-Isomer
Tetrahydrocannabinol, (6a-trans)-Isomer
Tetrahydrocannabinol (6aS-cis)-Isomer
Tetrahydrocannabinol (6aR-cis)-Isomer
Solvay Brand of Tetrahydrocannabinol
Tetrahydrocannabinol Trans-Isomer Tetrahydrocannabinol Trans Isomer delta(9)-Tetrahydrocannabinol
delta(1)-Tetrahydrocannabinol
9-ene-Tetrahydrocannabinol
9 ene Tetrahydrocannabinol
Tetrahydrocannabinol
delta(9)-THC delta(1)-THC Dronabinol Marinol THC |
30.987411207576
|
| 10005673 |
HU-331
|
|
137252-25-6 |
≥95%
|
|
|
2005-09-09
|
39.848813177818
|
hu-331
|
|
cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids cbs sythetic |
39.848813177818
|
| 70275 |
IMMA
|
|
- |
≥98%
|
|
|
|
12.406973603437
|
imma
|
Indomethacin Morpholinylamide; BML-190
|
cannabinoids receptors CB2 neuroscience neurochemistry endocrinology |
12.406973603437
|
| 10008661 |
JP104
Exclusive
|
|
- |
≥98%
|
|
✓ |
2006-09-05
|
7.391034655951
|
jp104
|
|
click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry |
7.391034655951
|
| 10266 |
JWH 007
Exclusive
|
|
155471-10-6 |
≥98%
|
|
✓ |
2011-02-23
|
32.475658424607
|
jwh-007
|
|
agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 |
32.475658424607
|
| 10486 |
JWH 007-d9
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
|
2010-10-11
|
38.180851749539
|
jwh-007-d9
|
|
agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 |
38.180851749539
|
| 9001058 |
JWH 011
Exclusive
|
|
155471-13-9 |
≥98%
|
|
✓ |
2011-09-06
|
22.113556607671
|
jwh-011
|
JWH 004 1-methylhexyl analog
|
JWH011 JWH-011 JWH11 JWH-11 JWH015 JWH-015 JWH15 JWH-15 JWHs analogs forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics central peripheral |
22.113556607671
|
| 10009018 |
JWH 015
|
|
155471-08-2 |
≥98%
|
|
|
2006-10-05
|
63.861233412638
|
jwh-015
|
|
agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 |
63.861233412638
|
| 10660 |
JWH 015-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-02-21
|
44.219281767956
|
jwh-015-d7
|
|
agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 |
44.219281767956
|
| 10849 |
JWH 016
Exclusive
|
|
155471-09-3 |
≥95%
|
|
✓ |
2011-07-13
|
39.249040409395
|
jwh-016
|
|
JWH016 JWH-016 cannabinoids CBs receptors isomers forensics sciences JWHs agonists cannabimimetics CB1 CB2 receptors agonists spices synthetics |
39.249040409395
|
| 10900 |
JWH 018
|
|
209414-07-3 |
≥98%
|
|
|
2011-05-05
|
28.369097520404
|
jwh-018
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 |
28.369097520404
|
| 9000844 |
JWH 018 2-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-10-26
|
19.190639893467
|
jwh-018-2-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
19.190639893467
|
| 10711 |
JWH 018 2-hydroxyindole metabolite-d9
Exclusive
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
✓ |
2011-02-25
|
12.710481456396
|
jwh-018-2-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
12.710481456396
|
| 9001004 |
JWH 018 2'-naphthyl isomer
Exclusive
|
|
1131605-25-8 |
≥98%
|
|
✓ |
2011-06-20
|
29.137832547709
|
jwh-018-2-naphthyl-isomer
|
|
JWH018 JWH-018 CBs cannabinoids forensics sciences cannabimimetic CB1 CB2 receptors agonist spices synthetic |
29.137832547709
|
| 9001006 |
JWH 018 2'-naphthyl-N-(1,2-dimethylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
9.060741372904
|
jwh-018-2-naphthyl-n-1-2-dimethylpropyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic herbal blends isomers JWH-018 JWH018 JWH18 JWH-18 18 |
9.060741372904
|
| 11586 |
JWH 018 2’-naphthyl-N-(1-ethylpropyl) isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-04-03
|
60.270715257992
|
jwh-018-2-naphthyl-n-1-ethylpropyl-isomer
|
|
neuroscience synthetic cannabinoids CBs herbals blends isomers forensics cannabimimetics CB1 CB2 receptors agonists central peripheral spices |
60.270715257992
|
| 9001009 |
JWH 018 2'-naphthyl-N-(1-methylbutyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-20
|
18.298877751904
|
jwh-018-2-naphthyl-n-1-methylbutyl-isomer
|
|
JWH018 JWH-018 CBs cannabinoids forensics sciences cannabimimetic CB1 CB2 receptor agonist spices synthetic |
18.298877751904
|
| 9001008 |
JWH 018 2'-naphthyl-N-(2,2-dimethylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-28
|
13.821061205240
|
jwh-018-2-naphthyl-n-2-2-dimethylpropyl-isomer
|
|
JWH-018 JWH018 JWH-18 JWH18 JWH 18 cannabinoids CBs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices synthetics |
13.821061205240
|
| 9001010 |
JWH 018 2'-naphthyl-N-(2-methylbutyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-13
|
12.288551387083
|
jwh-018-2-naphthyl-n-2-methylbutyl-isomer
|
|
JWH-018 JWH018 JWH 18 JWH18 JWH-18 forensics cbs cannabinoids isomers cannabimimetic CB1 CB2 receptors agoinsts spices synthetic pentyl chains herbal blends |
12.288551387083
|
| 9001005 |
JWH 018 2'-naphthyl-N-(3-methylbutyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-13
|
10.940436470858
|
jwh-018-2-naphthyl-n-3-methylbutyl-isomer
|
|
JWHs isomers forensic science cannabinoids CBs JWH-018 JWH018 JWH18 JWH-18 CB1 CB2 receptors agonist spices synthetic |
10.940436470858
|
| 9000851 |
JWH 018 4-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
29.965426746809
|
jwh-018-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
29.965426746809
|
| 10712 |
JWH 018 4-hydroxyindole metabolite-d9
Exclusive
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
✓ |
2011-02-25
|
15.974211548210
|
jwh-018-4-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
15.974211548210
|
| 9000852 |
JWH 018 5-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
31.649293691525
|
jwh-018-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
31.649293691525
|
| 10713 |
JWH 018 5-hydroxyindole metabolite-d9
Exclusive
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
✓ |
2011-03-11
|
16.057740414512
|
jwh-018-5-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
16.057740414512
|
| 9000853 |
JWH 018 6-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
30.292668565763
|
jwh-018-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
30.292668565763
|
| 10714 |
JWH 018 6-hydroxyindole metabolite-d9
Exclusive
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
✓ |
2011-03-25
|
29.737593084863
|
jwh-018-6-hydroxyindole-metabolite-d9
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
29.737593084863
|
| 10697 |
JWH 018 6-methoxyindole analog
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-02-15
|
19.075558118861
|
jwh-018-6-methoxyindole-analog
|
|
analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 |
19.075558118861
|
| 9000854 |
JWH 018 7-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
26.744422027828
|
jwh-018-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
26.744422027828
|
| 10715 |
JWH 018 7-hydroxyindole metabolite-d9
Exclusive
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
✓ |
2011-07-26
|
8.456755434286
|
jwh-018-7-hydroxyindole-metabolite-d9
|
|
WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
8.456755434286
|
| 9000799 |
JWH 018 adamantyl analog
Exclusive
|
|
- |
≥97%
|
|
✓ |
2011-07-18
|
42.958777573540
|
jwh-018-adamantyl-analog
|
AB-001
|
JWH 018 JWH-018 JWHs analogs forensics sciences cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics |
42.958777573540
|
| 9001193 |
JWH 018 adamantyl carboxamide
Exclusive New
|
|
1345973-50-3 |
≥98%
|
|
✓ |
2012-03-08
|
139.322541233127
|
jwh-018-adamantyl-carboxamide
|
2NE1; APICA
|
JWHs JWH018 JWH-018 JWH18 JWH 18 JWH-18 cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics science neuroscience synthetic central peripheral herbal blends analogs |
139.322541233127
|
| 13824 |
JWH 018-d9 (solution)
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
|
2010-06-21
|
48.264956879881
|
jwh-018-d9-solution
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 |
48.264956879881
|
| 9001000 |
JWH 018 N-(1,1-dimethylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-11-16
|
8.808625499578
|
jwh-018-n-1-1-dimethylpropyl-isomer
|
|
cannabinoids cannabimimetics CBs CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH018 JWH-018 JWH18 JWH 18 JWH-18 isomers herbal central peripheralpentyl chains |
8.808625499578
|
| 9001003 |
JWH 018 N-(1,2-dimethylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
10.446707583240
|
jwh-018-n-1-2-dimethylpropyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic herbal blends isomers JWH-018 JWH018 JWH18 JWH-18 18 |
10.446707583240
|
| 11585 |
JWH 018 N-(1-ethylpropyl) isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-04-03
|
81.793275619358
|
jwh-018-n-1-ethylpropyl-isomer
|
|
neuroscience synthetic cannabinoids CBs herbals blends isomers forensics cannabimimetics CB1 CB2 receptors agonists central peripheral spices |
81.793275619358
|
| 9001002 |
JWH 018 N-(1-methylbutyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-17
|
13.607471345279
|
jwh-018-n-1-methylbutyl-isomer
|
JWH 073 1-methylbutyl homolog
|
JWH-018 JWH018 CBs cannasbinoids forensic sciences cannabimimetic CB1 CB2 receptors agonist spices synthetic |
13.607471345279
|
| 9001001 |
JWH 018 N-(2,2-dimethylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-27
|
16.964924358661
|
jwh-018-n-2-2-dimethylpropyl-isomer
|
|
JWH018 JWH-018 JWH18 JWH-18 JWH 18 cannabinoids CBs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices forensic synthetics |
16.964924358661
|
| 11119 |
(±)-JWH 018 N-(2-hydroxypentyl) metabolite
New
|
|
- |
≥98%
|
|
|
2011-12-07
|
27.955279721688
|
-jwh-018-n-2-hydroxypentyl-metabolite
|
|
cannabinoids metabolites incense forensics urine urinary herbals JWHs JWH018 JWH-018 JWH 18 JWH18 JWH-18 serum alkyl cytochromes P450 CBs potent synthetic herbal blends CYP450 CYP-450 serum urine |
27.955279721688
|
| 10690 |
JWH 018 N-(2-methylbutyl) isomer
Exclusive
|
|
- |
≥97%
|
|
✓ |
2011-03-16
|
18.135527365523
|
jwh-018-n-2-methylbutyl-isomer
|
JWH 073 2-methylbutyl homolog
|
cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 |
18.135527365523
|
| 11118 |
(±)-JWH 018 N-(3-hydroxypentyl) metabolite
|
|
- |
≥98%
|
|
|
2011-11-17
|
24.623797326563
|
-jwh-018-n-3-hydroxypentyl-metabolite
|
|
cannabinoids metabolites incense forensics urine urinary herbal CBs JWHs JWH018 JWH-018 JWH 18 JWH18 JWH-18 monohydroxylation alkyl chainscytochromes P450 serum |
24.623797326563
|
| 10691 |
JWH 018 N-(3-methylbutyl) isomer
|
|
- |
≥97%
|
|
|
2011-02-07
|
18.534992637709
|
jwh-018-n-3-methylbutyl-isomer
|
JWH 073 3-methylbutyl homolog
|
cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 |
18.534992637709
|
| 11075 |
JWH 018 N-(4,5-epoxypentyl) analog
|
|
- |
≥98%
|
|
|
2011-10-21
|
22.906958377970
|
jwh-018-n-4-5-epoxypentyl-analog
|
JWH 018 epoxide
|
cannabinoids CBs cannabimimetic CB1 CB2 receptor agonists spices forensics synthetic herbal central peripheral alkyl chains |
22.906958377970
|
| 10921 |
(−)-JWH 018 N-(4-hydroxypentyl) metabolite
New
|
|
- |
≥98%
|
|
|
2011-12-07
|
23.904092435465
|
-jwh-018-n-4-hydroxypentyl-metabolite
|
|
cannabinoids CBs metabolites incense forensics urine urinary herbal blends JWHs JWH018 JWH-018 JWH 18 JWH-18 JWH18 enantiomers potent synthetic phase 1 phase I phase one glucuronidated enantiomer |
23.904092435465
|
| 10920 |
(+)-JWH 018 N-(4-hydroxypentyl) metabolite
New
|
|
- |
≥98%
|
|
|
2011-12-07
|
32.497115079313
|
-jwh-018-n-4-hydroxypentyl-metabolite
|
|
cannabinoids CBs metabolites incense forensics urine urinary herbal blends JWHs JWH018 JWH-018 JWH 18 JWH-18 JWH18 enantiomers phase 1 phase I phase one metabolism enantiomer glucuronidated |
32.497115079313
|
| 10796 |
(±)-JWH 018 N-(4-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥97%
|
|
✓ |
2011-05-31
|
30.827097139518
|
-jwh-018-n-4-hydroxypentyl-metabolite
|
|
JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures |
30.827097139518
|
| 10926 |
(±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-06-28
|
48.189223825681
|
-jwh-018-n-4-hydroxypentyl-metabolite-d5
|
|
JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry |
48.189223825681
|
| 11047 |
JWH 018 N-(5-bromopentyl) analog
New
|
|
- |
≥98%
|
|
|
2012-01-19
|
32.302845590090
|
jwh-018-n-5-bromopentyl-analog
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral analogs JWH-018 JWH018 JWH 18 JWH18 JWH-18 JWHs herbal blends bromine pentyl chains |
32.302845590090
|
| 10521 |
JWH 018 N-(5-chloropentyl) analog
New
|
|
- |
≥95%
|
|
|
2012-01-17
|
45.193105703607
|
jwh-018-n-5-chloropentyl-analog
|
|
cannabinoids CBs cannabimimetics CB1 CB2, receptors agonists spices forensics synthetic JWH018 JWH-018 JWH 18 JWH18 JWH-18 JWHs herbal blends analogs chlorine pentyl chains |
45.193105703607
|
| 9000855 |
JWH 018 N-(5-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
112.481585773088
|
jwh-018-n-5-hydroxypentyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
112.481585773088
|
| 10933 |
JWH 018 N-(5-hydroxypentyl) metabolite-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-06-22
|
65.383411098240
|
jwh-018-n-5-hydroxypentyl-metabolite-d5
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
65.383411098240
|
| 10958 |
JWH 018 N-(5-hydroxypentyl) β-D-Glucuronide
Exclusive New
|
|
- |
≥95%
|
|
✓ |
2011-12-20
|
55.837719564571
|
jwh-018-n-5-hydroxypentyl-d-glucuronide
|
|
JWH-018 JWH018 JWH-18 JWH18 JWHs cannabinoids CBs forensics sciences conjugates metabolites glucuronide incense urine urinary herbal |
55.837719564571
|
| 9000856 |
JWH 018 N-pentanoic acid metabolite
Exclusive
|
|
- |
≥95%
|
|
✓ |
2010-09-01
|
83.447861697431
|
jwh-018-n-pentanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
83.447861697431
|
| 9000867 |
JWH 018 N-pentanoic acid metabolite-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
✓ |
2010-09-15
|
231.759091679792
|
jwh-018-n-pentanoic-acid-metabolite-d4
|
|
JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
231.759091679792
|
| 13169 |
JWH 018 (solution)
|
|
209414-07-3 |
≥98%
|
|
|
2009-03-12
|
47.491561336422
|
jwh-018-solution
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 |
47.491561336422
|
| 13633 |
JWH 019
|
|
209414-08-4 |
≥98%
|
|
|
2010-01-14
|
51.392604445863
|
jwh-019
|
|
cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 |
51.392604445863
|
| 9000764 |
JWH 019 5-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-06
|
17.245524861878
|
jwh-019-5-hydroxyindole-metabolite
|
JWH 019-M2
|
JWH019 JWH-019 JWH-19 JWH 19 JWH19 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetic smoking urinary urine serum neuroscience CBs |
17.245524861878
|
| 9000765 |
JWH 019 N-(6-hydroxyhexyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-13
|
23.631270718231
|
jwh-019-n-6-hydroxyhexyl-metabolite
|
|
JWH019 JWH-019 JWH-19 JWH 19 JWH19 JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serum herbal blends metabolized livers |
23.631270718231
|
| 10850 |
JWH 020
Exclusive
|
|
209414-09-5 |
≥98%
|
|
✓ |
2011-06-02
|
42.261104716287
|
jwh-020
|
|
cannabinoids CBs cannabimimetic CB1 receptors agonists CB2 forensics bath salts JWH020 JWH-020 WIN55212-1 WIN55212-2 WIN-55212-1 WIN-55212-2 WIN552121 WIN552122 in vivo JWH 020 |
42.261104716287
|
| 9001056 |
JWH 022
Exclusive
|
|
209414-16-4 |
≥98%
|
|
✓ |
2011-08-09
|
81.900196852686
|
jwh-022
|
AM2201 N-(4-pentenyl) analog
|
JWH022 JWH-022 JWH22 JWH-22 JWHs cannabinoids CBs synthetic standards forensics sciences |
81.900196852686
|
| 10831 |
JWH 030
Exclusive
|
|
162934-73-8 |
≥98%
|
|
✓ |
2011-10-11
|
25.915750473185
|
jwh-030
|
|
JWH-030 JWH030 JWH30 JWH-30 JWH30 cannabimimetic cannabinoids synthetics CB1 CB2 CBs receptors forensics neuroscience naphtholyl pyrrole mouse mice inhibits inhibition inhibitors electrically induced vas deferens |
25.915750473185
|
| 10824 |
JWH 031
New
|
|
162934-74-9 |
≥98%
|
|
|
2012-02-17
|
35.576244985832
|
jwh-031
|
|
JWH-031 JWH031 JWH31 JWH-31 JWH31 JWHs cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral mice |
35.576244985832
|
| 9001201 |
JWH 072
New
|
|
209414-06-2 |
≥98%
|
|
|
2012-03-02
|
43.335915114003
|
jwh-072
|
|
cannabinoids CBs forensics neuroscience cannabimimetic CB1 CB2 receptors spice herbal central peripheral synthetic JWHs JWH072 JWH-072 JWH 72 JWH-72 JWH72 |
43.335915114003
|
| 10904 |
JWH 073
|
|
208987-48-8 |
≥97%
|
|
|
2011-05-06
|
35.953065587533
|
jwh-073
|
|
cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 |
35.953065587533
|
| 10633 |
JWH 073 2-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2011-01-11
|
31.011945190575
|
jwh-073-2-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs JWH073 JWH-073 cannabinoids cbs synthetic JWH 73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
31.011945190575
|
| 10716 |
JWH 073 2-hydroxyindole metabolite-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-03-10
|
13.307377506650
|
jwh-073-2-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
13.307377506650
|
| 10848 |
JWH 073 2-methylnaphthyl analog
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
29.764054293704
|
jwh-073-2-methylnaphthyl-analog
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics herbal blends JWH-073 073 JWH73 JWH-73 JWHs 73 |
29.764054293704
|
| 9001014 |
JWH 073 2'-naphthyl isomer
Exclusive
|
|
- |
≥97%
|
|
✓ |
2011-06-13
|
11.246485437555
|
jwh-073-2-naphthyl-isomer
|
|
JWHs isomers forensic sciences cannabinoids CBs JWH 73 JWH73 JWH-73 JWH073 JWH-073 cannabimimetic receptors Cb1 CB2 agonists spices synthetic herbal blends |
11.246485437555
|
| 9001016 |
JWH 073 2'-naphthyl-N-(1-methylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-28
|
12.482283404952
|
jwh-073-2-naphthyl-n-1-methylpropyl-isomer
|
|
JWH-073 JWH073 JWH-73 JWH73 JWH 73 cannabinoids CBs forensics sciences cannabimimetics CB1 CB2 receptors agonists spices synthetics |
12.482283404952
|
| 9001015 |
JWH 073 2'-naphthyl-N-(2-methylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-21
|
10.850114407839
|
jwh-073-2-naphthyl-n-2-methylpropyl-isomer
|
|
JWH-073 JWH073 JWH-73 JWH73 JWHs CBs cannabinoids forensic sciences cannabimimetic CB1 CB2 receptors agonists spices synthetic |
10.850114407839
|
| 9000861 |
JWH 073 4-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2010-09-01
|
31.007088490801
|
jwh-073-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
31.007088490801
|
| 10717 |
JWH 073 4-hydroxyindole metabolite-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-02-21
|
6.044669013027
|
jwh-073-4-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
6.044669013027
|
| 9001076 |
JWH 073 4-methylnaphthyl analog
|
|
- |
≥98%
|
|
|
2011-09-06
|
34.341054498329
|
jwh-073-4-methylnaphthyl-analog
|
JWH 122 N-butyl analog; 1-butyl-3-(1-(4-methyl)naphthoyl) indole
|
JWH073 JWH-073 JWH73 JWH-73 analogs hybrids forensics sciences cannabinoids CBs JWHs indoles cannabimimetics JWH 018 122 smoking incense spices forensics pains neuroscience |
34.341054498329
|
| 9000862 |
JWH 073 5-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
26.670627826984
|
jwh-073-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
26.670627826984
|
| 10718 |
JWH 073 5-hydroxyindole metabolite-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-03-11
|
10.114667254961
|
jwh-073-5-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
10.114667254961
|
| 9000863 |
JWH 073 6-hydroxyindole metabolite
Exclusive
|
|
- |
≥95%
|
|
✓ |
2010-09-01
|
24.845264190709
|
jwh-073-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
24.845264190709
|
| 10719 |
JWH 073 6-hydroxyindole metabolite-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-03-11
|
5.957007871222
|
jwh-073-6-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
5.957007871222
|
| 9000864 |
JWH 073 7-hydroxyindole metabolite
Exclusive
|
|
- |
98%
|
|
✓ |
2010-09-01
|
20.294200571000
|
jwh-073-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
20.294200571000
|
| 10720 |
JWH 073 7-hydroxyindole metabolite-d7
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-07-25
|
2.962005138349
|
jwh-073-7-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
2.962005138349
|
| 9000868 |
JWH 073-d7 (solution)
Exclusive
|
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2010-08-10
|
34.439604184391
|
jwh-073-d7-solution
|
|
deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 |
34.439604184391
|
| 9001013 |
JWH 073 N-(1,1-dimethylethyl) isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-01-12
|
21.552955906945
|
jwh-073-n-1-1-dimethylethyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH073 JWH-073 central peripheral herbal blends butyl chains isomers |
21.552955906945
|
| 9001012 |
JWH 073 N-(1-methylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-22
|
12.828383284451
|
jwh-073-n-1-methylpropyl-isomer
|
|
JWH073 JWH-073 JWH73 JWH-73 forensics sciences cannabinoids CBs JWHs cannabimimetics CB1 CB2 receptors agonists spices synthetic |
12.828383284451
|
| 9001011 |
JWH 073 N-(2-methylpropyl) isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-21
|
11.158274237773
|
jwh-073-n-2-methylpropyl-isomer
|
|
JWH-073 JWH073 JWH-73 JWH73 JWHs CBs cannabinoids forensic sciences cannabimimetic CB1 CB2 receptors agonists spices synthetic |
11.158274237773
|
| 10795 |
(±)-JWH 073 N-(3-hydroxybutyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-05-31
|
38.503368091955
|
-jwh-073-n-3-hydroxybutyl-metabolite
|
|
JWH-073 JWH073 JWH73 JWH-73 JWH73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures |
38.503368091955
|
| 10927 |
(±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-07-25
|
34.000722142645
|
-jwh-073-n-3-hydroxybutyl-metabolite-d5
|
|
deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience |
34.000722142645
|
| 9000865 |
JWH 073 N-(4-hydroxybutyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
94.571567053504
|
jwh-073-n-4-hydroxybutyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
94.571567053504
|
| 10934 |
JWH 073 N-(4-hydroxybutyl) metabolite-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-10-14
|
60.928260173248
|
jwh-073-n-4-hydroxybutyl-metabolite-d5
|
|
M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices |
60.928260173248
|
| 9000866 |
JWH 073 N-butanoic acid metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-09-01
|
84.149065798149
|
jwh-073-n-butanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
84.149065798149
|
| 9000870 |
JWH 073 N-butanoic acid metabolite-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2010-09-20
|
81.275709907057
|
jwh-073-n-butanoic-acid-metabolite-d5
|
|
JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
81.275709907057
|
| 13170 |
JWH 073 (solution)
|
|
208987-48-8 |
≥97%
|
|
|
2009-03-02
|
42.977244992795
|
jwh-073-solution
|
|
cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 |
42.977244992795
|
| 10579 |
JWH 081
|
|
210179-46-7 |
≥98%
|
|
|
2010-10-22
|
63.246342720480
|
jwh-081
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 |
63.246342720480
|
| 9001044 |
JWH 081 2-methoxynaphthyl isomer
Exclusive
|
|
824960-76-1 |
≥98%
|
|
✓ |
2011-08-23
|
20.306138663643
|
jwh-081-2-methoxynaphthyl-isomer
|
JWH 267
|
JWH-081 JWH081 JWH-81 JWH81 JWHs isomers forensics sciences cannabinoids CBs JWH267 JWH-267 cannabimimetics CB1 CB2 receptors agonists spices synthetics |
20.306138663643
|
| 9001045 |
JWH 081 3-methoxynaphthyl isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-01-25
|
28.522489911432
|
jwh-081-3-methoxynaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH-081 JWH081 JWH81 JWH-81 JWH 81 central peripheral |
28.522489911432
|
| 9001046 |
JWH 081 5-methoxynaphthyl isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
18.641213339628
|
jwh-081-5-methoxynaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic JWH-081 JWH081 JWH-18 JWH48 18 isomers |
18.641213339628
|
| 9001047 |
JWH 081 6-methoxynaphthyl isomer
Exclusive New
|
|
824961-41-3 |
≥98%
|
|
✓ |
2012-01-19
|
27.884690218810
|
jwh-081-6-methoxynaphthyl-isomer
|
JWH 166
|
cannabinoids CBs cannabimimetics central CB1 CB2 peripheral receptors agonists spices forensics synthetic isomers methoxy groups naphthyl rings research JWH081 JWH-081 JWH 81 JWH-81 JWH81 JWH166 JWH-166 JWHs |
27.884690218810
|
| 9001048 |
JWH 081 7-methoxynaphthyl isomer
Exclusive
|
|
824961-61-7 |
≥98%
|
|
✓ |
2011-10-11
|
19.629397573782
|
jwh-081-7-methoxynaphthyl-isomer
|
JWH 164
|
JWH 164 JWH164 JWH-164 cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic JWH-081 JWH081 JWH-81 JWH81 81 isomers |
19.629397573782
|
| 10511 |
JWH 081-d9
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
|
2011-09-08
|
34.895498379446
|
jwh-081-d9
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
34.895498379446
|
| 9000768 |
JWH 081 N-(5-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-08-05
|
33.587906619445
|
jwh-081-n-5-hydroxypentyl-metabolite
|
|
JWH-081 JWH081 JWH-81 JWH81 JWH 81 JWHs CBs cannabinoids forensics sciences metabolites cannabimimetics metabolites CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum |
33.587906619445
|
| 10680 |
JWH 098
Exclusive
|
|
316189-74-9 |
≥98%
|
|
✓ |
2011-04-20
|
38.943367530193
|
jwh-098
|
|
JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles |
38.943367530193
|
| 10591 |
JWH 122
|
|
619294-47-2 |
≥98%
|
|
|
2010-12-15
|
91.021638971897
|
jwh-122
|
|
JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs 1 2 CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids cbs synthetic |
91.021638971897
|
| 9001032 |
JWH 122 2-methylnaphthyl isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-05-16
|
249.235232469323
|
jwh-122-2-methylnaphthyl-isomer
|
|
JWH-122 JWH122 JWHs isomers forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics |
249.235232469323
|
| 9001033 |
JWH 122 3-methylnaphthyl isomer
|
|
- |
≥98%
|
|
|
2011-11-08
|
104.035829239431
|
jwh-122-3-methylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic synthetic herbal methyl naphthyl isomers JWH122 JWH-122 JWHs |
104.035829239431
|
| 9001034 |
JWH 122 5-methylnaphthyl isomer
|
|
- |
≥98%
|
|
|
2011-11-08
|
103.417044709044
|
jwh-122-5-methylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH122 JWH-122 synthetic herbal methyl naphthyl isomers central peripheral |
103.417044709044
|
| 9001035 |
JWH 122 6-methylnaphthyl isomer
Exclusive New
|
|
- |
≥95%
|
|
✓ |
2012-05-16
|
255.662939793352
|
jwh-122-6-methylnaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics herbal blends isomers JWH-122 JWH122 |
255.662939793352
|
| 9001036 |
JWH 122 7-methylnaphthyl isomer
Exclusive New
|
|
824960-56-7 |
≥98%
|
|
✓ |
2012-05-16
|
264.137606460019
|
jwh-122-7-methylnaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetic herbal blends isomers JWH-122 JWH122 |
264.137606460019
|
| 9001037 |
JWH 122 8-methylnaphthyl isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-05-16
|
187.170934667690
|
jwh-122-8-methylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic JWH-122 JWH122 herbalmethyl groups naphthyl rings herbal |
187.170934667690
|
| 10512 |
JWH 122-d9
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
|
2011-09-08
|
82.701417264663
|
jwh-122-d9
|
|
JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
82.701417264663
|
| 11784 |
JWH 122 N-(4-hydroxypentyl) metabolite
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-05-21
|
177.343209960627
|
jwh-122-n-4-hydroxypentyl-metabolite
|
|
cannabinoids forensics CB1 CB2 metabolites metabolism designer drugs neuroscience CBs JWH-210 JWH210 JWH122 JWH-122 serum urine |
177.343209960627
|
| 11611 |
JWH 122 N-(4-pentenyl) analog
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-04-20
|
169.727469987228
|
jwh-122-n-4-pentenyl-analog
|
MAM2201 N-(4-pentenyl) analog; JWH 022 4-methylnaphthyl analog
|
cannabinoids CBs forensics CB1 CB2 analogs designer drugs JWH122 neuroscience JWH-122 synthetics central peripheral MAM2201 JWH 022 JWH022 JWH-022 |
169.727469987228
|
| 10925 |
JWH 122 N-(5-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-17
|
62.067860111477
|
jwh-122-n-5-hydroxypentyl-metabolite
|
MAM2201 N-(5-hydroxypentyl) metabolite
|
cannabinoids CBs receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 |
62.067860111477
|
| 11475 |
JWH 122 N-(5-hydroxypentyl) metabolite-d5
Exclusive New
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2012-04-27
|
177.815253720284
|
jwh-122-n-5-hydroxypentyl-metabolite-d5
|
MAM2201 N-(5-hydroxypentyl) metabolite-d5
|
LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids cbs synthetic receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 |
177.815253720284
|
| 10825 |
JWH 145
Exclusive
|
|
914458-19-8 |
≥95%
|
|
✓ |
2011-11-10
|
24.008926127631
|
jwh-145
|
|
JWH-145 JWH145 JWHs cannabinoids CBs CB1 CB2 herbals smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH018 JWH-018 JWH 018 blends 73 18 JWH073 JWH-073 JWH 073 JWH73 JWH 73 JWH-73 JWH18 JWH-18 |
24.008926127631
|
| 10826 |
JWH 147
New
|
|
914458-20-1 |
≥95%
|
|
|
2012-03-06
|
38.607296567102
|
jwh-147
|
|
JWH147 JWH-147 JWHs CBs smoking receptors agaonists aminoalkylindoles cannabinoids central peripheral cannabimimetic CB1 CB2 spices forensics neuroscience pain herbal |
38.607296567102
|
| 11201 |
JWH 175
Exclusive New
|
|
619294-35-8 |
≥98%
|
|
✓ |
2012-02-09
|
33.281770722897
|
jwh-175
|
|
CBs JWH-175 JWH175 JWHs CB1 CB2 cannabinoids JWH018 JWH-018 JWH 018 receptors agonist spices synthetic |
33.281770722897
|
| 9001205 |
JWH 180
New
|
|
824959-87-7 |
≥98%
|
|
|
2012-03-26
|
67.051033200285
|
jwh-180
|
|
JWH-180 JWH180 cannabinoids CBs designer drugs cannabimimetics CB1 CB2 receptors agonists herbals blends synthetics central peripheral forensics |
67.051033200285
|
| 10643 |
JWH 182
Exclusive
|
|
824960-02-3 |
≥97%
|
|
✓ |
2011-10-11
|
37.014994360320
|
jwh-182
|
|
JWH-182 JWHs CB1 CB2 CBs receptors agonists pains spices forensics synthetics cannabinoids cells animals |
37.014994360320
|
| 10902 |
JWH 200
|
|
103610-04-4 |
≥98%
|
|
|
2011-05-05
|
23.047589726815
|
jwh-200
|
|
cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 |
23.047589726815
|
| 9000897 |
JWH 200 2'-naphthyl isomer
Exclusive
|
|
133438-66-1 |
≥98%
|
|
✓ |
2011-06-20
|
14.291077348066
|
jwh-200-2-naphthyl-isomer
|
|
JWH200 JWH-200 CBs cannabinoids forensics sciences cannabimimetic CB1 receptors agonist spices synthetic |
14.291077348066
|
| 10744 |
JWH 200 4-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-04-15
|
29.918738489871
|
jwh-200-4-hydroxyindole-metabolite
|
|
JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine |
29.918738489871
|
| 10745 |
JWH 200 5-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-06
|
19.416322020521
|
jwh-200-5-hydroxyindole-metabolite
|
|
JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine neuroscience |
19.416322020521
|
| 10746 |
JWH 200 6-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
25.816933701657
|
jwh-200-6-hydroxyindole-metabolite
|
|
JWH200 JWH-200 cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetics smoking urinary urine aminoalkylindoles binds binding high-affinity high affinity JWHs |
25.816933701657
|
| 10747 |
JWH 200 7-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2011-11-21
|
16.661862667718
|
jwh-200-7-hydroxyindole-metabolite
|
|
JWH200 JWH-200 cannabinoids cannabimimetics metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine aminoalkylindole JWH 015 JWH 018 JWH015 JWH018 JWH-015 JWH-018 JWH15 JWH18 JWH 15 JWH 18 JWH-15 JWH-18 |
16.661862667718
|
| 10903 |
JWH 200-d5
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
2011-05-06
|
7.401256906077
|
jwh-200-d5
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 |
7.401256906077
|
| 10682 |
JWH 200-d5 (solution)
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
|
2011-01-07
|
35.027270718231
|
jwh-200-d5-solution
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 |
35.027270718231
|
| 13171 |
JWH 200 (solution)
|
|
103610-04-4 |
≥98%
|
|
|
2009-03-25
|
42.655236723869
|
jwh-200-solution
|
|
cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 |
42.655236723869
|
| 10721 |
JWH 201
Exclusive
|
|
864445-47-6 |
≥98%
|
|
✓ |
2011-02-24
|
52.971855179095
|
jwh-201
|
|
cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 |
52.971855179095
|
| 9000736 |
JWH 203
|
|
864445-54-5 |
≥98%
|
|
|
2011-02-21
|
60.724386917343
|
jwh-203
|
|
cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic |
60.724386917343
|
| 10868 |
JWH 203 3-chlorophenyl isomer
Exclusive
|
|
864445-56-7 |
≥98%
|
|
✓ |
2011-06-03
|
27.553149171271
|
jwh-203-3-chlorophenyl-isomer
|
JWH 237; JWH 203 3-chloro isomer
|
cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 CBs cannabimimetics forensics pain bath salts phenylacetylindole analog |
27.553149171271
|
| 10867 |
JWH 203 4-chlorophenyl isomer
Exclusive
|
|
864445-58-9 |
≥98%
|
|
✓ |
2011-06-02
|
35.659226519337
|
jwh-203-4-chlorophenyl-isomer
|
JWH 206; JWH 203 4-chloro isomer
|
cannabinoids CB1 CB2 receptors synthetic forensics pain bath salts CBs JWH203 JWH-203 JWH206 JWH-206 |
35.659226519337
|
| 10644 |
JWH 210
|
|
824959-81-1 |
≥98%
|
|
|
2011-02-01
|
91.721299146051
|
jwh-210
|
|
cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 |
91.721299146051
|
| 9001038 |
JWH 210 2-ethylnaphthyl isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
13.341907063722
|
jwh-210-2-ethylnaphthyl-isomer
|
|
JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetics smoking urinary urine serums JWH-210 JWH210 alkyindoles herbal blends |
13.341907063722
|
| 9001039 |
JWH 210 3-ethylnaphthyl isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2011-11-30
|
15.530770432025
|
jwh-210-3-ethylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWHs JWH210 JWH-210 alkylindole herbal blends isomers ethyl chains naphthyl groups |
15.530770432025
|
| 9001040 |
JWH 210 5-ethylnaphthyl isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-11-17
|
15.487964321381
|
jwh-210-5-ethylnaphthyl-isomer
|
|
cannabinoids cannabimimetics metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serum alkylindoles herbal blends isomers JWH-210 JWH210 |
15.487964321381
|
| 9000771 |
JWH 210 5-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-08-10
|
14.867951564468
|
jwh-210-5-hydroxyindole-metabolite
|
|
JWH-210 JWH210 cannabinoids CBs cannabimimetic metabolites CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
14.867951564468
|
| 9001041 |
JWH 210 6-ethylnaphthyl isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-01-31
|
27.473526939369
|
jwh-210-6-ethylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic smoking JWH210 JWH-210 JWHs isomers alkylindoles extracts herbal blends |
27.473526939369
|
| 9001042 |
JWH 210 7-ethylnaphthyl isomer
Exclusive
|
|
824960-64-7 |
≥98%
|
|
✓ |
2011-10-11
|
15.493589635294
|
jwh-210-7-ethylnaphthyl-isomer
|
JWH 234
|
JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serums JWH-234 JWH234 JWH-210 JWH210 alkylindoles herbal blends |
15.493589635294
|
| 9001043 |
JWH 210 8-ethylnaphthyl isomer
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-11-04
|
12.948135089839
|
jwh-210-8-ethylnaphthyl-isomer
|
|
JWH210 JWH-210 cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum herbal alkylindole isomers naphthyl groups |
12.948135089839
|
| 10510 |
JWH 210-d9
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
|
2011-09-08
|
28.281393228426
|
jwh-210-d9
|
|
cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain |
28.281393228426
|
| 10940 |
JWH 210 N-(4-hydroxypentyl) metabolite
New
|
|
- |
≥95%
|
|
|
2012-01-19
|
31.847586683177
|
jwh-210-n-4-hydroxypentyl-metabolite
|
|
cannabinoids CBs cannabimimetics metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWH210 JWH-210 JWHs alkylindoles liver |
31.847586683177
|
| 10941 |
JWH 210 N-(5-carboxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
28.047369688706
|
jwh-210-n-5-carboxypentyl-metabolite
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics smoking urinary urine serums JWH-210 210 liver excreted |
28.047369688706
|
| 9000772 |
JWH 210 N-(5-hydroxypentyl) metabolite
|
|
- |
≥98%
|
|
|
2011-11-04
|
17.738441468544
|
jwh-210-n-5-hydroxypentyl-metabolite
|
|
JWH 210 JWH210 cannabinoids CBs JWHs alkylindoles liver cannabimimetic metabolites CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
17.738441468544
|
| 11153 |
JWH 249
New
|
|
864445-60-3 |
≥98%
|
|
|
2012-02-10
|
28.643596557285
|
jwh-249
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH249 JWH-249 JWHs central peripheral |
28.643596557285
|
| 13634 |
JWH 250
|
|
864445-43-2 |
≥98%
|
|
|
2010-01-14
|
81.333491122734
|
jwh-250
|
|
cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic |
81.333491122734
|
| 9000766 |
JWH 250 5-hydroxyindole metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-20
|
46.724391608983
|
jwh-250-5-hydroxyindole-metabolite
|
|
JWH250 JWH-250 cannabinoids CBs cannabimimetics metabolite CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
46.724391608983
|
| 10661 |
JWH 250-d5
Exclusive
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-02-14
|
37.389532481263
|
jwh-250-d5
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 |
37.389532481263
|
| 10939 |
JWH 250 N-(4-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-24
|
54.240961699935
|
jwh-250-n-4-hydroxypentyl-metabolite
|
|
JWHs JWH-250 JWH250 metabolites cannabinoids CB1 CB2 CBs herbal smoke smoking forensics receptors agonist cannabimimetic metabolite metabolism |
54.240961699935
|
| 10938 |
JWH 250 N-(5-carboxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-19
|
69.224958016694
|
jwh-250-n-5-carboxypentyl-metabolite
|
|
JWHs JWH-250 JWH250 metabolites forensics sciences urinary urine synthetics cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum |
69.224958016694
|
| 9000767 |
JWH 250 N-(5-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-08-05
|
56.847280509968
|
jwh-250-n-5-hydroxypentyl-metabolite
|
|
JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum |
56.847280509968
|
| 11474 |
JWH 250 N-(5-hydroxypentyl) metabolite-d5
Exclusive New
|
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2012-04-27
|
122.875777105692
|
jwh-250-n-5-hydroxypentyl-metabolite-d5
|
|
deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS synthetic JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum JWH-18 JWH 18 JWH18 JWH018 JWH-018 JWH 018 JWH 15 JWH-15 JWH15 JWH015 JWH-015 JWH 015 |
122.875777105692
|
| 10578 |
JWH 251
|
|
864445-39-6 |
≥98%
|
|
|
2010-08-20
|
44.132323069158
|
jwh-251
|
|
cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic |
44.132323069158
|
| 9001021 |
JWH 251 3-methylphenyl isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-10-11
|
19.794696132596
|
jwh-251-3-methylphenyl-isomer
|
JWH 251 3-methyl isomer
|
cannabinoids receptors CB1 CB2 CBs WIN55212-2 WIN-552122 WIN-55212-2 WIN 55,2122 WIN 55,212-2 cannabimimetics urine forensic JWH-251 JWH251 adulterant |
19.794696132596
|
| 9001022 |
JWH 251 4-methylphenyl isomer
Exclusive
|
|
864445-41-0 |
≥98%
|
|
✓ |
2011-10-14
|
10.688563535911
|
jwh-251-4-methylphenyl-isomer
|
JWH 251 4-methyl isomer
|
JWH-251 JWH251 CBs cannabinoids receptors WIN 55212-2 WIN55212 WIN 55,212-2 WIN 55,2122 CB1 CB2 cannabimimetics urine forensics |
10.688563535911
|
| 10722 |
JWH 302
Exclusive
|
|
864445-45-4 |
≥95%
|
|
✓ |
2011-03-04
|
58.664660429136
|
jwh-302
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding |
58.664660429136
|
| 10797 |
JWH 307
New
|
|
914458-26-7 |
≥96%
|
|
|
2011-12-15
|
54.650958008575
|
jwh-307
|
|
JWH307 JWH-307 cannabinoids CBs CB1 CB2 herbal smoking forensics receptors agonists JWHs cannabimimetic psychological neurological nuerology toxicological toxicology |
54.650958008575
|
| 10830 |
JWH 309
Exclusive New
|
|
914458-42-7 |
≥98%
|
|
✓ |
2012-02-28
|
31.150459420982
|
jwh-309
|
|
JWH309 JWH-309 cannabinoids forensic science neuroscience cannabimimetic CB1 CB2 receptors spices herbal central peripheral |
31.150459420982
|
| 10829 |
JWH 368
New
|
|
914458-31-4 |
≥98%
|
|
|
2011-12-14
|
35.244410394511
|
jwh-368
|
|
JWH368 JWH-368 cannabinoids CBs CB1 CB2 herbal smoking forensics sciences receptors agonists cannabimimetic JWHs |
35.244410394511
|
| 10828 |
JWH 369
New
|
|
914458-27-8 |
≥95%
|
|
|
2012-01-25
|
28.568664451965
|
jwh-369
|
|
JWH369 JWH-369 cannabinoids cannabimimetics CB1 CB2 CBs receptors agonists spices forensics synthetic central peripheral mouse research |
28.568664451965
|
| 10827 |
JWH 370
|
|
914458-22-3 |
≥95%
|
|
|
2011-11-10
|
23.615292190691
|
jwh-370
|
|
JWH370 JWH-370 JWHs cannabinoids CB1 CB2 herbal smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH 018 JWH 18 JWH-018 JWH018 JWH073 JWH 73 JWH 073 JWH-073 analogs blends JWH-73 JWH73 JWH-18 JWH18 |
23.615292190691
|
| 13636 |
JWH 398
Exclusive
|
|
- |
≥95%
|
|
✓ |
2010-10-22
|
75.850922185528
|
jwh-398
|
|
jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic |
75.850922185528
|
| 9001023 |
JWH 398 2-chloronaphthyl isomer
|
|
- |
≥95%
|
|
|
2011-11-09
|
13.148088908318
|
jwh-398-2-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic herbal mixtures isomers chloro naphthyl JWH398 JWH-398 JWHs |
13.148088908318
|
| 9001024 |
JWH 398 3-chloronaphthyl isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-01-11
|
20.466262453979
|
jwh-398-3-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH398 JWH-398 JWHs isomers herbal mixtures chlorine naphthyl rings central peripheral |
20.466262453979
|
| 9001025 |
JWH 398 5-chloronaphthyl isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-08-23
|
17.593459146997
|
jwh-398-5-chloronaphthyl-isomer
|
|
JWH398 JWH-398 forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics central peripheral |
17.593459146997
|
| 9001026 |
JWH 398 6-chloronaphthyl isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-11-04
|
17.018972886219
|
jwh-398-6-chloronaphthyl-isomer
|
|
JWH398 JWH-398 cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic isomers herbal mixtures chloro groups naphthyl rings |
17.018972886219
|
| 9001027 |
JWH 398 7-chloronaphthyl isomer
|
|
- |
≥98%
|
|
|
2011-11-16
|
17.360886500225
|
jwh-398-7-chloronaphthyl-isomer
|
|
cannabinoids cannabimimetics CBs CB1 CB2 receptor agonists spices forensics synthetic JWHs JWH398 JWH-398 isomers herbal chloro groups naphthyl rings |
17.360886500225
|
| 9001028 |
JWH 398 8-chloronaphthyl isomer
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-01-13
|
23.049348494365
|
jwh-398-8-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers herbal mixtures JWHs JWH-398 JWH398 central peripheral |
23.049348494365
|
| 10514 |
JWH 398-d9
Exclusive
|
|
- |
≥99% deuterated forms (d1-d9)
|
|
✓ |
2011-08-25
|
38.562490444706
|
jwh-398-d9
|
|
JWH398 JWH-398 standards cannabinoids CBs JWHs forensics sciences deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS |
38.562490444706
|
| 9000770 |
JWH 398 N-(5-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-06
|
22.685776002988
|
jwh-398-n-5-hydroxypentyl-metabolite
|
|
JWH398 cannabinoids CBs JWH-398 forensic sciences JWHs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetics |
22.685776002988
|
| 9001203 |
JWH 424
New
|
|
- |
≥98%
|
|
|
2012-02-27
|
32.938874205072
|
jwh-424
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH424 JWH-424 JWH018 JWH-018 JWH 18 JWH-18 JWH18 herbal blends |
32.938874205072
|
| 13158 |
JZL 184
|
|
1101854-58-3 |
≥97%
|
|
|
2009-01-26
|
215.123167587476
|
jzl-184
|
|
2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids |
215.123167587476
|
| 13668 |
JZL 195
|
|
121004-12-8 |
≥98%
|
|
|
2010-02-10
|
222.909116022099
|
jzl-195
|
|
fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes
1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles |
222.909116022099
|
| 10640 |
KM 233
Exclusive
|
|
628263-22-9 |
≥98%
|
|
✓ |
2011-07-07
|
30.745445845929
|
km-233
|
|
KM233 KM-233 CBs cannabinoids CB2 agonists recptors CB1 gliomas anti tumors cancers |
30.745445845929
|
| 10009280 |
L-759,633
|
|
174627-50-0 |
>98%
|
|
|
2007-09-13
|
33.291215469613
|
l-759-633
|
|
L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic |
33.291215469613
|
| 10008618 |
Lauric Acid Leelamide
|
|
- |
>98%
|
|
|
2006-09-05
|
0.377171270718
|
lauric-acid-leelamide
|
|
saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 12-carbons coconut nut oils COX-2 cyclooxygenase-2 cyclooxygenases expressions C:8-18 inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine leelamine cannabinoids cbs synthetic |
0.377171270718
|
| 10006148 |
Leelamine
|
|
1446-61-3 |
>98%
|
|
|
2006-05-10
|
0.274861878453
|
leelamine
|
Dehydroabietylamine
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic |
0.274861878453
|
| 10008614 |
Leelamine (hydrochloride)
|
|
- |
≥98%
|
|
|
2006-05-10
|
0.154696132596
|
leelamine-hydrochloride
|
Dehydroabietylamine
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic |
0.154696132596
|
| 13453 |
LH 21
|
|
611207-11-5 |
≥98%
|
|
|
2011-03-22
|
20.343434622468
|
lh-21
|
|
cannabimimetic CBs cannabinoids CB1 receptors antagonists pain weight gain obesity LH-21 LH21 central |
20.343434622468
|
| 9001219 |
MAM2201
Exclusive New
|
|
1354631-24-5 |
≥98%
|
|
✓ |
2012-03-28
|
330.627994973750
|
mam2201
|
AM2201 4-methylnaphthyl analog; JWH 122 N-(5-fluoropentyl) analog
|
cannabinoids CBs CB1 CB2 cannabimimetics receptors herbals spices designer drugs AM-2201 AM 2201 MAM-2201 MAM 2201 analogs synthetics central peripheral forensics JWH122 JWH 122 JWH-122 |
330.627994973750
|
| 10563 |
MDA 19
|
|
1048973-47-2 |
≥95%
|
|
|
2010-09-17
|
47.691606156274
|
mda-19
|
|
agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor
Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor
|
47.691606156274
|
| 10639 |
MDA 77
Exclusive
|
|
1103774-21-5 |
≥98%
|
|
✓ |
2011-05-16
|
2.672099447514
|
mda-77
|
|
CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay |
2.672099447514
|
| 10979 |
MDMA methylene homolog (hydrochloride)
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-22
|
31.106511302061
|
mdma-methylene-homolog-hydrochloride
|
3,4-Methylenedioxymethamphetamine methyl homolog
|
forensic sciences cannabinoids CBs pyrovalerones pentylones designer drugs forensics neuroscience psychoactive ecstasy HCl |
31.106511302061
|
| 10007704 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
Exclusive
|
|
183718-75-4 |
>98%
|
|
✓ |
2007-02-02
|
9.847955801105
|
n-3-hydroxyphenyl-arachidonoyl-amide
|
3-HPAA
|
neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic |
9.847955801105
|
| 10007431 |
N-Arachidonoyl Dopamine-d8
|
|
- |
≥99% deuterated forms (d1-d8)
|
|
|
2005-08-10
|
10.190939226519
|
n-arachidonoyl-dopamine-d8
|
NADA-d8
|
deuterateds analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids ada cb1 cb2 analgesic arachidonoyl-dopamine neurochemistry neuroscience deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass 10007431 spectrometry cannabinoids cbs synthetic |
10.190939226519
|
| 10005455 |
N-Arachidonoyl-L-Serine
|
|
187224-29-9 |
>98%
|
|
|
2004-08-11
|
7.062702159718
|
n-arachidonoyl-l-serine
|
ARA-S
|
endocannabinoids antagonists cannabidiols neuroprotective neurotransmitters hypotensive effects antagonize antagonist neurochemistry neuroscience cannabinoids cbs synthetic |
7.062702159718
|
| 10005609 |
N-Oleoyl Taurine
Exclusive
|
|
52514-04-2 |
≥98%
|
|
✓ |
2005-01-05
|
7.001404235727
|
n-oleoyl-taurine
|
|
endocannibinoids fatty amides oleamides taurines amino-acyls lipidomics profiling fatty acids neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
7.001404235727
|
| 10006803 |
O-1602
|
|
317321-41-8 |
>98%
|
|
|
2005-09-12
|
11.877928176795
|
o-1602
|
|
abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic |
11.877928176795
|
| 10006804 |
O-1821
|
|
35482-50-9 |
>97%
|
|
|
2005-09-12
|
26.649907918968
|
o-1821
|
|
abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic |
26.649907918968
|
| 10004914 |
O-1918
|
|
536697-79-7 |
>98%
|
|
|
2005-09-09
|
11.646172059984
|
o-1918
|
|
antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic |
11.646172059984
|
| 10009195 |
O-2545 (hydrochloride)
|
|
- |
≥98%
|
|
|
2007-07-12
|
5.521546961326
|
o-2545-hydrochloride
|
|
cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic |
5.521546961326
|
| 10007823 |
Oleoyl Ethanolamide-d2
|
|
- |
≥99% deuterated forms (d1-d2)
|
|
|
2006-03-06
|
17.913535911602
|
oleoyl-ethanolamide-d2
|
OEA-d2; Oleic Acid Ethanolamide-d2
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
17.913535911602
|
| 9000552 |
Oleoyl Ethanolamide-d4
Exclusive
|
|
- |
≥99% deuterated forms (d1- d4)
|
|
✓ |
2010-01-12
|
10.248737174428
|
oleoyl-ethanolamide-d4
|
Oleic Acid Ethanolamide-d4; OEA-d4
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic |
10.248737174428
|
| 10005459 |
Oleoyl Ethyl Amide
Exclusive
|
|
85075-82-7 |
>98%
|
|
✓ |
2004-07-21
|
22.870906077348
|
oleoyl-ethyl-amide
|
N-Ethyloleamide; OEtA
|
endocannabinoids analogs FAAH fatty acid amide hydrolase analgesic inhibitors inhibitor inhibition acyl PEAase anxiolytic inhibits selective selectivity neuroscience neurochemistry cannabinoids cbs synthetic |
22.870906077348
|
| 10965 |
Palmitoleoyl Ethanolamide
|
|
94421-67-7 |
≥98%
|
|
|
2011-06-27
|
20.839465930018
|
palmitoleoyl-ethanolamide
|
POEA
|
cannabinoids endocannabinoids CBs N-acylethanolamines signalling N-acylethanolamides NAEs signaling receptors pain lipid-derived |
20.839465930018
|
| 13279 |
PF-3845
|
|
1196109-52-0 |
≥98%
|
|
|
2010-01-27
|
43.794327808471
|
pf-3845
|
|
fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal
Monoclonal Antibodies |
43.794327808471
|
| 71655 |
PHOP
|
|
288862-83-9 |
>98%
|
|
|
2005-02-02
|
8.605465666929
|
phop
|
Phenyl hexanoyl oxazolopyridine; CAY10402
|
FAAH fatty acids amides hydrolases inhibits inhibitors inhibition cannabinoids CB1 CB2 hydrolysis hydrolyze CAY-10402 TGH triacylglycerols neurochemistry neuroscience cbs synthetic |
8.605465666929
|
| 10006973 |
Pravadoline
|
|
92623-83-1 |
≥98%
|
|
|
2011-02-08
|
49.868317154124
|
pravadoline
|
WIN 48,098
|
Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles
receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 |
49.868317154124
|
| 13621 |
Pristimerin
Exclusive
|
|
1258-84-0 |
≥98%
|
|
✓ |
2010-03-08
|
49.274348855564
|
pristimerin
|
Celastrol methyl ester; NSC 99281
|
monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes |
49.274348855564
|
| 12015 |
Prostaglandin D2-1-glyceryl ester
|
|
309260-52-4 |
>95% (as a 9:1 mixture of the 1- and 2-glyceryl esters)
|
|
|
2004-08-05
|
35.810524861878
|
prostaglandin-d2-1-glyceryl-ester
|
PGD2-1-glyceryl ester
|
endocannabinoids anandamides 2AG fatty acids porcine brain isomerase moiety cannabinoids cbs synthetic |
35.810524861878
|
| 10192 |
Prostaglandin D2 serinol amide
|
|
- |
>98%
|
|
|
2004-05-13
|
38.065237569061
|
prostaglandin-d2-serinol-amide
|
PGD2-SA
|
PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA |
38.065237569061
|
| 10140 |
Prostaglandin E2-1-glyceryl ester
|
|
37497-47-5 |
>98% (as a 85:15 mixture of the 1- and 2-glyceryl esters)
|
|
|
|
50.722817679558
|
prostaglandin-e2-1-glyceryl-ester
|
PGE2-1-glyceryl ester
|
Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic |
50.722817679558
|
| 14012 |
Prostaglandin E2 Ethanolamide
Exclusive
|
|
194935-38-1 |
>98%
|
|
✓ |
|
43.989917127072
|
prostaglandin-e2-ethanolamide
|
PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2
|
anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides |
43.989917127072
|
| 10193 |
Prostaglandin E2 serinol amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2004-03-03
|
36.179234411997
|
prostaglandin-e2-serinol-amide
|
PGE2-SA
|
PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience |
36.179234411997
|
| 10139 |
Prostaglandin F2α-1-glyceryl ester
|
|
43042-79-1 |
>98% (as a 9:1 mixture of the 2- and 1-glyceryl esters)
|
|
|
|
17.860110497238
|
prostaglandin-f2-1-glyceryl-ester
|
PGF2α-1-glyceryl ester
|
Prostaglandins PGF2alpha-1-GE PGF2.alpha.-1-GE esters 2-AG 2-arachidonoyl-glycerol COX-2 metabolites cyclooxygenases PGHS-2 synthases PGHS2 COX2 PGF2alpha-2-GE PGF2.alpha.-2-GE PGFa-2-GE PGF2a-1-GE cannabinoids cbs synthetic |
17.860110497238
|
| 10194 |
Prostaglandin F2α serinol amide
|
|
- |
>98%
|
|
|
2004-02-23
|
14.588425414364
|
prostaglandin-f2-serinol-amide
|
PGF2α-SA
|
PGF2alphaSA PGF2.alpha.SA PGF2alpha-SA PGF2.alpha.-SA cannabinoids agonists CB1 recptors analogs 2-glyceryl esters amides neuroscience |
14.588425414364
|
| 10004281 |
R-1 Methanandamide Phosphate
|
|
- |
>98%
|
|
|
2004-08-20
|
21.225856353591
|
r-1-methanandamide-phosphate
|
R-1MAP; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate
|
endocannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors anandamides analogs agonists phosphates LPA lysophatidic acids neurochemistry neuroscience R1 cannabinoids cbs synthetic |
21.225856353591
|
| 10645 |
RCS-4
|
|
- |
≥98%
|
|
|
2010-11-24
|
116.736971034073
|
rcs-4
|
|
cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic |
116.736971034073
|
| 10865 |
RCS-4 2-methoxy isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-15
|
48.632737799022
|
rcs-4-2-methoxy-isomer
|
|
synthetic cannabinoids forensics receptors herbal spices incense JWH 250 JWH-250 JWH250 RCS4 RCS 4 analogs CB1 CB2 cannabimimetic indoles CBs |
48.632737799022
|
| 10866 |
RCS-4 3-methoxy isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-15
|
45.077700937744
|
rcs-4-3-methoxy-isomer
|
|
cannabinoids receptors JWH 018 CB1 CB2 CBs cannabimimetics forensics synthetic bath salts JWH-018 JWH018 |
45.077700937744
|
| 10798 |
RCS-4-C4 homolog
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-04-21
|
42.903849575109
|
rcs-4-c4-homolog
|
BTM-4; SR-19; OBT-199; E-4
|
cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetics smoking urinary urine serum JWH018 JWH 018 JWH-018 JWH18 BTM4 BTM 4 E4 E 4 OBT199 OBT 199 SR19 SR 19 |
42.903849575109
|
| 10513 |
RCS-4-d9
|
|
- |
≥99% deuterated product
|
|
|
2011-09-12
|
34.954514656230
|
rcs-4-d9
|
|
cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
34.954514656230
|
| 10936 |
RCS-4 N-(4-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-29
|
37.546372595367
|
rcs-4-n-4-hydroxypentyl-metabolite
|
|
cannabinoids cannabimimetics metabolites CB1 CB2 CBs receptors agonists spices synthetic smoking urinary urine RCS4 RCS 4 JWHs glucuroconjugate forensics sciences neuroscience |
37.546372595367
|
| 10937 |
RCS-4 N-(5-carboxypentyl) metabolite
|
|
- |
≥98%
|
|
|
2011-06-28
|
41.962303867402
|
rcs-4-n-5-carboxypentyl-metabolite
|
|
RCS4 RCS 4 forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics |
41.962303867402
|
| 10935 |
RCS-4 N-(5-hydroxypentyl) metabolite
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-06-17
|
48.680381189597
|
rcs-4-n-5-hydroxypentyl-metabolite
|
|
cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine RCS4 RCS 4 JWHs glucuroconjugate forensics sciences neuroscience |
48.680381189597
|
| 10636 |
RCS-8
|
|
- |
≥98%
|
|
|
2010-11-02
|
98.138615251861
|
rcs-8
|
SR-18
|
cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance
A2 Thromboxane Thromboxane A2 |
98.138615251861
|
| 10864 |
RCS-8 3-methoxy isomer
Exclusive
|
|
- |
≥98%
|
|
✓ |
2011-07-13
|
27.721609116022
|
rcs-8-3-methoxy-isomer
|
|
RCS 8 RCS8 isomers CBs cannabinoids forensics sciences RCS-4 RCS4 cannabimimetics CB1 CB2 receptors agonists spices synthetics extracts cannabis herbal blends |
27.721609116022
|
| 10863 |
RCS-8 4-methoxy isomer
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-07-13
|
34.160325966851
|
rcs-8-4-methoxy-isomer
|
|
RCS8 RCS 8 isomers forensics sciences RCS4 RCS-4 CBs cannabinoids cannabimimetics CB1 CB2 receptors agonists spices synthetics |
34.160325966851
|
| 9000484 |
Rimonabant
|
|
168273-06-1 |
≥98%
|
|
|
2009-06-17
|
74.152900552486
|
rimonabant
|
SR141716
|
SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic |
74.152900552486
|
| 10899 |
(R)-(−)-JWH 073 N-(3-hydroxybutyl) metabolite
|
|
- |
≥98%
|
|
|
2011-11-18
|
17.885706179660
|
-r-jwh-073-n-3-hydroxybutyl-metabolite
|
|
cannabinoids metabolites cannabimimetics forensics herbal blends spices adulterant enantiomer liver microsomes glucuronidate urine CBs JWHs JWH073 JWH-073 JWH 73 JWH73 JWH-73 |
17.885706179660
|
| 10898 |
(S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite
|
|
- |
≥98%
|
|
|
2011-11-18
|
17.439573582975
|
-s-jwh-073-n-3-hydroxybutyl-metabolite
|
|
cannabinoids metabolites cannabimimetic forensics herbal blends spices CBs JWH073 JWH-073 JWH 73 JWH73 JWH-73 JWHs enantiomer liver microsomes glucuronidate urine |
17.439573582975
|
| 10009226 |
(±)-SLV 319
Exclusive
|
|
362519-49-1 |
≥98%
|
|
✓ |
2007-01-16
|
25.542371440714
|
-slv-319
|
|
CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic |
25.542371440714
|
| 9000491 |
SR 144528
|
|
192703-06-3 |
≥98%
|
|
|
2009-08-05
|
72.405013812154
|
sr-144528
|
|
antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic |
72.405013812154
|
| 11564 |
STS-135
Exclusive New
|
|
1354631-26-7 |
≥98%
|
|
✓ |
2012-03-28
|
242.522906592621
|
sts-135
|
N-adamantyl-1-fluoropentylindole-3-Carboxamide
|
cannabinoids CBs herbals spices forensics CB1 CB2 receptors agonists designer drugs STS 135 STS135 fluoropentylindole AM2201 AM-2201 AM 2201 synthetics peripheral |
242.522906592621
|
| 13830 |
Synthetic Cannabinoid HPLC Mixture I
|
|
- |
≥95% for each compound
|
|
|
2010-05-13
|
40.045118847375
|
synthetic-cannabinoid-hplc-mixture-i
|
|
cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic |
40.045118847375
|
| 13850 |
Synthetic Cannabinoid HPLC Mixture II
|
|
- |
≥95% for each compound
|
|
|
2010-12-21
|
44.388457144890
|
synthetic-cannabinoid-hplc-mixture-ii
|
|
cannabinoids CBs synthetics mixtures receptors agonists synthetic |
44.388457144890
|
| 11335 |
Synthetic Cannabinoid HPLC Mixture III
New
|
|
- |
≥95% for each compound
|
|
|
2012-03-20
|
75.250490689850
|
synthetic-cannabinoid-hplc-mixture-iii
|
|
cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs RCS |
75.250490689850
|
| 11336 |
Synthetic Cannabinoid HPLC Mixture IV
New
|
|
- |
≥95% for each compound
|
|
|
2012-05-03
|
100.564303915699
|
synthetic-cannabinoid-hplc-mixture-iv
|
|
cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs |
100.564303915699
|
| 11337 |
Synthetic Cannabinoid HPLC Mixture V (AM Series)
New
|
|
- |
≥95% for each compound
|
|
|
2012-02-02
|
40.873690480371
|
synthetic-cannabinoid-hplc-mixture-v-am-series
|
|
AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 |
40.873690480371
|
| 11502 |
UR-144
New
|
|
1199943-44-6 |
≥98%
|
|
|
2012-04-02
|
409.791972624799
|
ur-144
|
KM-X1
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetics UR144 UR 144 peripheral central KMX-1 KMX 1 KM X1 |
409.791972624799
|
| 13261 |
URB447
Exclusive
|
|
1132922-57-6 |
≥98%
|
|
✓ |
2009-06-18
|
35.040220994475
|
urb447
|
|
CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic |
35.040220994475
|
| 10046 |
URB597
|
|
546141-08-6 |
>98%
|
|
|
|
47.222456052235
|
urb597
|
|
FAAH fatty acid amide hydrolases inhibitors URB-597 anandamides lipids inhibition selective selectivity AEA inhibits hydrolysis hydrolyze arachidonoyl cannabinoids ethanolamides neuroscience neurochemistry |
47.222456052235
|
| 10007457 |
URB602
|
|
565460-15-3 |
>98%
|
|
|
2005-09-06
|
40.775469613259
|
urb602
|
|
monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic |
40.775469613259
|
| 10007691 |
URB754
|
|
86672-58-4 |
>98%
|
|
|
2005-11-04
|
33.701977900552
|
urb754
|
|
neurochemistry neuroscience 2-AG 2-archidonoyl glyerol MGL monoacylglycerol lipase monoglyceride lipase endocannabinoids FAAH fatty acid amide hydrolase inhibitors inhibition inhibits monoglycerol MAGL neurochemistry cannabinoids |
33.701977900552
|
| 10674 |
URB937
Exclusive
|
|
1357160-72-5 |
≥95%
|
|
✓ |
2011-03-08
|
15.000916206261
|
urb937
|
|
FAAH anandamide AEA inhibitors peripheral pain Cannabinoids
|
15.000916206261
|
| 9001204 |
WIN 54461
Exclusive New
|
|
166599-63-9 |
≥98%
|
|
✓ |
2012-04-11
|
92.324171225580
|
win-54461
|
6-Bromopravadoline
|
cannabinoids CBs receptors CB1 CB2 antagonists neuroscience forensics WIN-54461 WIN54461 mimetics WIN 55212-2 WIN 552122 WIN-55212-2 WIN55212-2 aminoalikylindoles WIN 54,461 10009023 10763 vas deferens inhibition inhibits inhibitors |
92.324171225580
|
| 10009023 |
(+)WIN 55212-2 (mesylate)
|
|
131543-23-2 |
≥98%
|
|
|
2006-10-05
|
59.227790192713
|
-win-55212-2-mesylate
|
|
WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic |
59.227790192713
|
| 10736 |
(±)WIN 55212 (mesylate)
New
|
|
137795-17-6 |
≥98%
|
|
|
2012-01-11
|
46.514430542014
|
-win-55212-mesylate
|
|
cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral |
46.514430542014
|
| 11565 |
XLR11
Exclusive New
|
|
1364933-54-9 |
≥98%
|
|
✓ |
2012-04-10
|
391.634701678218
|
xlr11
|
|
cannabinoids CBs cannabimimetic receptors CB1 CB2 designer drugs forensics neuroscience XLR-11 XLR 11 central peripheral |
391.634701678218
|
| 11688 |
XLR11 N-(4-pentenyl) analog
Exclusive New
|
|
- |
≥98%
|
|
✓ |
2012-05-08
|
299.757058969709
|
xlr11-n-4-pentenyl-analog
|
UR-144 N-(4-pentenyl) analog
|
cannabinoids CBs CB1 CB2 forensics spices herbals neuroscience XLR-11 XLR 11 AM2201 MAM2201 AM 2201 AM-2201 MAM 2201 MAM-2201 analogs 11565 central peripheral receptors K2 UR144 UR 144 UR-144 pentenyl analog 10707 9001219 |
299.757058969709
|
| 90215 |
α-Linolenoyl Ethanolamide
Exclusive
|
|
57086-93-8 |
>98%
|
|
✓ |
|
9.920122336227
|
-linolenoyl-ethanolamide
|
|
cannabinoids neurotransmitters ethanolamides fatty acids CB alpha-linolenoyl .alpha.-linolenoyl cannabinergic neurochemistry neuroscience ethanolamines, cbs, synthetic |
9.920122336227
|